investing @Collab_Currency / @Dorm_DAO reply guy, dreamer

San Francisco, CA
Joined September 2014
1/ SCALING THROUGH DECENTRALIZATION This piece explores the motivations behind improving model performance in a decentralized setting. Link in next tweet.
171
22
14
376
35,339
That’s it I’m framing this one
President Trump says that Sundar Pichai talked him out of renaming the Atlantic Ocean. 'And I spoke to a brilliant guy, Sundar, he heads all of Google, he's a brilliant guy. Sergey and Sundar, totally brilliant guys. You know, they're still rattled from the Gulf. And I said, "Sundar, I'm thinking of the Atlantic Ocean, can you handle it?" "No, no, no, this time I’m not doing it," he said. He said, "Oceans are different, sir. You know, they cover, they cover really a lot of countries. Please don’t ask us to do that."
8
642
he smoking a cig on his lunch break before he has to go backpack the defense😭
watch mcdaniels as the shot go up bro is funny asf he emote every time somebody take a 3😂😂 bro put a cigarette out and stepped on it
6
808
Together AI capturing a lot of open weight market share on @OpenRouter went from 3% to 32.5% of third-party market share in the last month👀
2
7
725
@inference_net making a push! did about ~10% of 3rd party volume yday
1
121
@inference_net !! most market share for all 3rd party hosts at 14% on OR today
1
61
SOON AT THE WHITE HOUSE: President Donald J. Trump highlights the admin's efforts to crack down on foreign criminal networks ​that lure Americans into fraudulent crypto investments.
1
2
18
1,642
Doug coming back to bid whop of all businesses is kinda awesome idk what the proper analogy is but Andre Drummond developing a 3-pointer after 13 seasons in the league comes to mind
I waited, learned and made my first investment since returning as an active investor at Sequoia. Whop is a special company, and I’m excited to help them to create jobs and stimulate the economy.
25
1,470
Sarah on a heater rn, a lot of intellectual high horse behavior on businesses investors deem unsustainable yet mrkt and revenues are telling u they are Great post on opportunity in inference too: xitter.cf/saranormous/status/210…
the silliest way to lose a lot of money in 2026 is to hold onto stupid priors for dear life the second silliest is to make “safe” bets behind prestige vs. first principles evaluation of tech/business. if a company has fancy pedigree but is just losing…don’t fight the tape
2
13
12,345
Gpod many avenues to get cheap tokens that are short-term or have latency/performance tradeoffs @dphnAI tackled the difficult engineering and distributed systems problems to create a network that unlocks consumer hardware at scale to offer cheaper inference, a durable advantage they will leverage this efficiency advantage by offering products and services on top, such as Flipper, their multi-agent engineering harness over time, you can imagine that this distributed 24/7 network can dynamically route throughput to other computation workloads in times of under-utilization This can include: - Training custom uncensored models in-house - Post training as a service for external parties - Data-generation for hillclimbing verifiable domains - Large scale web scraping via distributed set of nodes The distributed inference network is the base layer that they intend to capitalize on through other products and technologies can read about the larger vision here: dphn.ai/project/
base:0xed664536023d8e4b1640c394777d34abaff1df8f served ~32bn DeepSeek API tokens through its inference network over the last 24hrs - around 6% of the ~500bn/day Venice reported last week - whilst the network remains in effectively closed beta.... Usage is still predominantly running on promotional credits so not a revenue signal (yet), but the throughput confirms the network is capable of production-scale volume. 💪
5
4
1
19
1,630
We just killed cold outreach. Introducing Leadpoet: the AI sales agent that finds buyers who need you now, writes personalized outreach, and follows up on LinkedIn and email. Used by Dropbox, OnePatch (YC26), Muttdata. Comment “Poet” for 100 free lead credits to find qualified buyers.
509
92
68
562
120,719
Ronan retweeted
A brokerage for you and your AI. Infinite: your own infinite trading canvas, built widget by widget or by asking AI. Mobile: the markets wherever you go, with Bloomberg TV and TradingView charts. @financedotdev: the API it all runs on, with our own MCP.
🤖 Made with AI
I love trading but feel like brokerage are mostly the same. 1. APIs are an afterthought 2. Low quality execution on mobile 3. The desktop apps all look the same! today we’re launching our own brokerage aries.com try it!
31
58
15
281
234,553
✍️✍️✍️
Replying to @JayaGup10
Thanks ChatGPT! You’re absolutely…not right. When I was saying check your numbers — I didn’t mean total training cluster build commitments, I meant the 95% GRR, 400% NDR of the inference leaders. That is best-in-class stickiness and close partnership with every significant customer, not “reverse auction with a one line api change.” What does a Neocloud model that builds and sells its compute in long term commitments, underwritten against IG credit, get you in the inference business? It doesn’t get you the serving stack, the production muscle, the customer trust, or the freely allocated supply. Inference is a huge market, and it’s likely that new companies will find new niches. Like Digital Ocean after AWS. But in a supply constrained market you’re betting somehow the new players find a better use of the supply than the existing players. What does a new player at the bottom have as a business advantage? These businesses need to maximize dollars per MW in order to even afford the compute for their customers. Unless they’ve got strategic friends, where are they going to get their supply? If they can only peel off the most cost sensitive, lowest margin workloads as a cold start (say, batch?) and can’t fit it into an overall cloud’s utilization picture, how can they afford market supply? Without the engine to identify and underwrite new suppliers in a sea of scammers, how can they even find it? If your customers grow…you quickly need a gigawatt. People only talk about megawatts because they can’t afford it. In inference, I’d attack supply and not demand — I would be most excited to hear about a new player that has a clever idea of where they, uniquely, are going to get a gigawatt. VC funding is the silliest indicator of startup success. It is also, by dollars, going to get drowned out by the funding the inference players raise. Hundred of millions is small ball. You think the leaders are serving generic weights? It’s 90% custom, 1000s of different models, and any given big customer uses a constellation of models (often tens) in their product. Post training (and specifically training and tuning against our stack) is an engine that produces more value for our customers, that they reinvest the savings in customer growth, better product and in inference on us. Customers are wonderfully hungry, and so a good inference company will rapidly deliver them more: sandboxes, ecosystems and better abstractions. This is not a liquid commodity game, it’s a platform one, with a supply prerequisite. Anyone big who splits traffic only does amongst a small number of leaders, with custom models. And they do not churn — unless you can’t keep up with their growth, or fuck up reliability or security.
6
708
Sama waiting for his DPRK kickback:
*OPENAI EYES ACQUISITION OF CRYPTO SECURITY COMPANY TRAIL OF BITS: THE INFORMATION
1
5
407
illiquid PoW coins make good times good times make liquid PoW coins liquid PoW coins make bad times bad times make illiquid PoW coins
Ladies and gentlemen, we are preparing for landing. Please fasten your seat belts, return your seat backs to the upright position, stow your tray tables and open your window shades. Thank you.
4
1
13
1,318
Increasingly, the economic usefulness of AI and agents is a function of their live information coverage and latency excited to see Grass roll out LCR
Replying to @grass
The Contents API is built using the Grass Network and designed to retrieve pages that conventional web infrastructure struggles to access. In our latest benchmark, Grass successfully retrieved 98% of pages in our hard-domain test set, compared to 71% for the next-best provider.
1
2
35
1,739
The personal agent era was nice while it lasted. It’s tailscale or bust from here on out.
2
127
their beautiful non cyclical infinite demand memory our disgusting short term slop RL envs
Startups selling data to AI labs are putting up unprecedented sales growth but it makes sense. In the stock market semis selling memory/compute to AI labs are the best growth stories and AI improvement is basically compute + data.
1
5
443
imagine if they run back the AI trade but in Bio OAI/Ant existence proof that the incredibly well capitalized, shoot for the moon strategy works - funds can justify data vendors pop up to sell to labs with too much money autonomous bio labs <> hyperscalers/neoclouds
2 new business models in the discovery time in 5 years: - neolabs for bio - next-gen CROs that are selling proprietary data to frontier labs and biotechs many questions about moats (neolabs) and durability (CROs) but ramp to 9-figure revenue is tangible and relatively rare in biotech.
3
1
12
1,819
6-12 months ago the large labs started buying bio data this spend is starting to ramp very aggressively. the labs are somewhat indiscriminate buyers with enormous budgets. the therapeutics market has long had buyers of data (large and small pharma) but they've historically been the exact opposite of huge-budget and indiscriminate this shift will distort the bio startup market in a bunch of ways. there will be a lot of short-termist behavior to try to get in front of this capital firehouse. but unlike the AI data labelers (mercor, et al) and the robotics labelers (mecka, et al), the bio startups serving up this data have a chance to emerge from this period with businesses that don't rely on selling data the best bio startups will use these sudden resources the labs are dumping on them to supercharge their novel assay and work towards independently powerful models and eventually directly produce therapies bio is the final frontier and its a very exciting time ahead for bio startups IMO
96